ROS101,A Novel Targeted Methotrexate Prodrug, Selectively Activated by Reactive Oxygen Species (ROS) Shows Reduced Tixicity in Rat CIA Model of Rheumatic Arthritis

V. Previtali, N. Woodworth, M. H. Hopkins, J. H. Petersen, I. Ahnfelt-Ronne, M. H. Clausen

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
Article numberP142
JournalAnnals of the Rheumatic Diseases
Volume78
Issue numberSuppl. 1
Pages (from-to)A62-A63
Number of pages2
ISSN0003-4967
DOIs
Publication statusPublished - 2019
Event39th European Workshop for Rheumatology Research - Lyon, France
Duration: 28 Feb 20192 Mar 2019

Workshop

Workshop39th European Workshop for Rheumatology Research
CountryFrance
CityLyon
Period28/02/201902/03/2019

Cite this